# Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-69

> **NCT00047515** · PHASE3 · COMPLETED · sponsor: **Alcon Research**

## Conditions studied

- Open-Angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Alcon Investigational Agent

## Key facts

- **NCT ID:** NCT00047515
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-01
- **Primary completion:** 2003-12
- **Final completion:** 2003-12
- **Target enrollment:** — (—)
- **Last updated:** 2008-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00047515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00047515, "Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-69". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00047515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*